Clinical Trial Update: Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating total-body irradiation with cyclophosphamide as conditioning before donor stem cell transplant in hematologic cancers; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Syndromes

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED